Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: A meta-analysis of randomised controlled trials

  • Amr F. Barakat
  • , Marwan Saad
  • , Akram Y. Elgendy
  • , Amgad Mentias
  • , Ahmed Abuzaid
  • , Ahmed N. Mahmoud
  • , Islam Y. Elgendy

Producción científica: Articlerevisión exhaustiva

27 Citas (Scopus)

Resumen

Objectives The objective of this meta-analysis of randomised controlled trials (RCTs) is to evaluate the role of primary prevention implantable cardioverter defibrillator (ICD) in patients with non-ischaemic cardiomyopathy (NICM). Setting A meta-analysis of RCTs performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Data sources The PubMed, MEDLINE, Embase and Cochrane Central Register of Controlled Trials databases were searched for relevant articles. Participants A total of 5 RCTs with 2573 patients with NICM were included. Intervention Primary prevention ICD, compared with medical therapy alone. Primary and secondary outcome measures All-cause mortality (primary outcome) and sudden cardiac death (SCD, secondary outcome). Data analysis Summary estimate HR were constructed using the random-effect DerSimonian and Laird's model. Multiple study-level subgroup analyses were performed, and interaction was tested using random-effect analysis. Results Compared with medical therapy alone, ICD placement was associated with lower risk of all-cause mortality (HR 0.79; 95% CI 0.64 to 0.93; p<0.001; I 2 =0%) at a mean follow-up of 4.2 years. The risk of SCD was also lower with ICD placement (RR 0.47; 95% CI 0.30 to 0.73; p=0.001; I 2 =0%) compared with control. On subgroup analyses, there was a suggestion of possible effect modification by age, in which benefit was observed in age group <60 years (HR 0.64; 95% CI 0.47 to 0.89), but not with age ≥60 years (HR 0.82; 95% CI 0.65 to 1.03) (P interaction =0.058), but not with other study-level variables. Conclusions Compared with medical therapy alone, primary prevention ICD therapy in patients with NICM is associated with a significant reduction in all-cause mortality, especially in younger patients. Future dedicated studies are needed to investigate the role of primary prevention ICD in the elderly population.

Idioma originalEnglish
Número de artículoe016352
PublicaciónBMJ Open
Volumen7
N.º6
DOI
EstadoPublished - jun 1 2017

Nota bibliográfica

Publisher Copyright:
© 2017 Article author(s).

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: A meta-analysis of randomised controlled trials'. En conjunto forman una huella única.

Citar esto